State Medicaid P&T Committee Meeting
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Pharmacy and Therapeutics Committee
Notice Information
- Notice Title
- State Medicaid P&T Committee Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- February 16, 2023 07:00 AM
- Event End Date & Time
- February 16, 2023 08:45 AM
- Event Deadline Date & Time
- 02/16/23 08:45 AM
- Description/Agenda
- Pharmacy & Therapeutics Committee Meeting Agenda Thursday, February 16, 2023 7:00 a.m. to 8:45 a.m. Google Meet joining information Video call link: https://meet.google.com/hej-yhvk-ues Or dial: (US) +1 781-342-1136 PIN: 250 067 695# Persons who wish to address the P&T Committee may contact Bryan S Larson at (bslarson@utah.gov) prior to the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Cole Sloan, PharmD, Chair a) Announce Quorum 2) Welcome and Introductions - Cole Sloan, PharmD, Chair a) Review and Approval of Minutes b) Housekeeping 3) DUR Board Update - Ngan Huynh, PharmD 4) Review a) Non--Stimulants for the Treatment of ADHD - Monet Luloh, PharmD i) atomoxetine, clonidine ER, guanfacine ER, viloxazine b) Public Comment c) Committee Discussion/Questions d) Committee Action 5) Next Meeting Thursday, May 18, 2023 Topic: Anti-obesity treatments 6) Adjourned - Cole Sloan, PharmD, Chair Individuals with questions about accessibility or requesting special accommodations for this meeting should contact Bryan S Larson at bslarson@utah.gov or (801) 538-6149. The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to: Dr. Joanne LaFleur College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Month 18 May 2023 Topic Anti-obesity treatments Agents benzphetamine, bupropion/naltrexone, diethylpropion (ER and IR), liraglutide, orlistat, phendimetrazine, phentermine, semalgutide, topiramate/phentermine Month 21 Sep 2022 Topic Insulin Pumps Agents TBD Month 16 Nov 2022 Topic Anti-VEGF Agents TBD
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Bryan Larson at 801-538-6149.
- Notice of Electronic or Telephone Participation
- Google Meet joining information Video call link: https://meet.google.com/hej-yhvk-ues Or dial: (US) +1 781-342-1136 PIN: 250 067 695#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Ngan Huynh
- Contact Email
- nganhuynh@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- February 07, 2023 04:28 PM
- Notice Last Edited On
- February 07, 2023 04:28 PM
- Deadline Date
- February 16, 2023 08:45 AM
Subscribe
Subscribe by Email
Subscription options will send you alerts regarding future notices posted by this Body.